D. Tastekin Et Al. , "Clinical significance of serum caveolin-1 levels in melanoma.," 50th Annual Meeting of the American-Society-of-Clinical-Oncology , vol.32, Illinois, United States Of America, 2014
Tastekin, D. Et Al. 2014. Clinical significance of serum caveolin-1 levels in melanoma.. 50th Annual Meeting of the American-Society-of-Clinical-Oncology , (Illinois, United States Of America).
Tastekin, D., KARABULUT, S., DURANYILDIZ, D., & Tas, F., (2014). Clinical significance of serum caveolin-1 levels in melanoma. . 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America
Tastekin, Didem Et Al. "Clinical significance of serum caveolin-1 levels in melanoma.," 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 2014
Tastekin, Didem Et Al. "Clinical significance of serum caveolin-1 levels in melanoma.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America, 2014
Tastekin, D. Et Al. (2014) . "Clinical significance of serum caveolin-1 levels in melanoma.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Didem TAŞTEKİN Et Al. }, title={Clinical significance of serum caveolin-1 levels in melanoma.}, congress name={50th Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Illinois}, country={United States Of America}, year={2014}}